{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T10:54:41.373253+00:00","published_at":"2026-10-16T04:46:51.907669+00:00","section":"board","data":{"state":"PUBLISHED","size":{"value":10,"assertion_class":"alpha_calculated_metric","basis":"Count of published current board seats in this Record. Roster completeness is not asserted.","input_claim_ids":["alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:5","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:6","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:7","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:8","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:9","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:10","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:11","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:12","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:13","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:14"]},"chair":null,"lead_independent_director":null,"ceo_chair_combined":null,"independence":{"value":{"independent_directors":8,"directors_with_determination":10,"published_directors":10,"independent_share":0.8},"assertion_class":"alpha_calculated_metric","basis":"Board independence determinations are source facts; the share is computed only over directors with a published determination.","input_claim_ids":["alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:5","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:6","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:7","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:8","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:9","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:10","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:11","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:12","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:13","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:14"]},"average_tenure_years":{"value":{"years":7.9,"directors_with_start_date":10},"assertion_class":"alpha_calculated_metric","basis":"Average tenure at the Record as-of time, bounded by appointment end dates; directors without a published start date are excluded.","input_claim_ids":["alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:5","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:6","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:7","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:8","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:9","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:10","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:11","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:12","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:13","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:14"]},"committee_load":{"value":{"average_memberships":1.71,"directors_with_memberships":7},"assertion_class":"alpha_calculated_metric","basis":"Average published committee memberships per current director with at least one published membership.","input_claim_ids":["alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:6","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:7","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:8","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:9","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:10","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:12","alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:14"]},"skills_coverage":null,"directors":[{"person":{"alpha_id":"alpha:person:andong-huang","name":"Amy (Yin-Zhen) Huang","canonical_url":"https://registry.alpha.ac/people/andong-huang"},"current_role":"Director","director_since":"2020-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2020-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:faisal-g-sukhtian","name":"Faisal G. Sukhtian","canonical_url":"https://registry.alpha.ac/people/faisal-g-sukhtian"},"current_role":"Director","director_since":"2017-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2017-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:faisal-g-sukhtian","name":"Faisal G. Sukhtian","canonical_url":"https://registry.alpha.ac/people/faisal-g-sukhtian"},"committee_id":"alpha:committee:outlook-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:25","evidence_ids":["alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:faisal-g-sukhtian","name":"Faisal G. Sukhtian","canonical_url":"https://registry.alpha.ac/people/faisal-g-sukhtian"},"committee_id":"alpha:committee:outlook-therapeutics-inc:nominating-and-governance-chair","committee_name":"Nominating and Governance · Chair","role":"member","valid_from":"2017-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Nominating and Governance"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:gerd-auffarth","name":"Gerd Auffarth","canonical_url":"https://registry.alpha.ac/people/gerd-auffarth"},"current_role":"Director","director_since":"2020-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2020-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:gerd-auffarth","name":"Gerd Auffarth","canonical_url":"https://registry.alpha.ac/people/gerd-auffarth"},"committee_id":"alpha:committee:outlook-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":"2020-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:25","evidence_ids":["alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:julia-a-haller","name":"Julia A. Haller","canonical_url":"https://registry.alpha.ac/people/julia-a-haller"},"current_role":"Director","director_since":"2022-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2022-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:julia-a-haller","name":"Julia A. Haller","canonical_url":"https://registry.alpha.ac/people/julia-a-haller"},"committee_id":"alpha:committee:outlook-therapeutics-inc:nominating-and-governance","committee_name":"Nominating and Governance","role":"member","valid_from":"2022-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:25","evidence_ids":["alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:julian-gangolli","name":"Julian Gangolli","canonical_url":"https://registry.alpha.ac/people/julian-gangolli"},"current_role":"Director","director_since":"2020-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2020-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:julian-gangolli","name":"Julian Gangolli","canonical_url":"https://registry.alpha.ac/people/julian-gangolli"},"committee_id":"alpha:committee:outlook-therapeutics-inc:audit","committee_name":"Audit","role":"member","valid_from":"2020-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:17","evidence_ids":["alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:kurt-j-hilzinger","name":"Kurt J. Hilzinger","canonical_url":"https://registry.alpha.ac/people/kurt-j-hilzinger"},"current_role":"Director","director_since":"2015-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2015-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:kurt-j-hilzinger","name":"Kurt J. Hilzinger","canonical_url":"https://registry.alpha.ac/people/kurt-j-hilzinger"},"committee_id":"alpha:committee:outlook-therapeutics-inc:audit","committee_name":"Audit","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:17","evidence_ids":["alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:kurt-j-hilzinger","name":"Kurt J. Hilzinger","canonical_url":"https://registry.alpha.ac/people/kurt-j-hilzinger"},"committee_id":"alpha:committee:outlook-therapeutics-inc:audit-chair-compensation","committee_name":"Audit · Chair; Compensation","role":"member","valid_from":"2015-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:kurt-j-hilzinger","name":"Kurt J. Hilzinger","canonical_url":"https://registry.alpha.ac/people/kurt-j-hilzinger"},"committee_id":"alpha:committee:outlook-therapeutics-inc:compensation","committee_name":"Compensation","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:21","evidence_ids":["alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Audit"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:lawrence-a-kenyon","name":"Lawrence A. Kenyon","canonical_url":"https://registry.alpha.ac/people/lawrence-a-kenyon"},"current_role":"Director","director_since":"2015-01-01","director_until":null,"status":"current","independent":{"value":false,"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2015-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:ralph-h-randy-thurman","name":"Ralph H. Randy Thurman","canonical_url":"https://registry.alpha.ac/people/ralph-h-randy-thurman"},"current_role":"Director","director_since":"2018-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2018-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:ralph-h-randy-thurman","name":"Ralph H. Randy Thurman","canonical_url":"https://registry.alpha.ac/people/ralph-h-randy-thurman"},"committee_id":"alpha:committee:outlook-therapeutics-inc:audit","committee_name":"Audit","role":"member","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:17","evidence_ids":["alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:ralph-h-randy-thurman","name":"Ralph H. Randy Thurman","canonical_url":"https://registry.alpha.ac/people/ralph-h-randy-thurman"},"committee_id":"alpha:committee:outlook-therapeutics-inc:audit-compensation-chair","committee_name":"Audit; Compensation · Chair","role":"member","valid_from":"2018-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:ralph-h-randy-thurman","name":"Ralph H. Randy Thurman","canonical_url":"https://registry.alpha.ac/people/ralph-h-randy-thurman"},"committee_id":"alpha:committee:outlook-therapeutics-inc:compensation","committee_name":"Compensation","role":"chair","valid_from":null,"valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:21","evidence_ids":["alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":["Compensation"],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:robert-c-jahr","name":"Robert C. Jahr","canonical_url":"https://registry.alpha.ac/people/robert-c-jahr"},"current_role":"Director","director_since":"2025-01-01","director_until":null,"status":"current","independent":{"value":false,"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2025-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"},{"person":{"alpha_id":"alpha:person:yezan-haddadin","name":"Yezan Haddadin","canonical_url":"https://registry.alpha.ac/people/yezan-haddadin"},"current_role":"Director","director_since":"2017-01-01","director_until":null,"status":"current","independent":{"value":true,"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported","valid_from":"2017-01-01","valid_to":null},"board_chair":false,"lead_independent_director":null,"committee_memberships":[{"person":{"alpha_id":"alpha:person:yezan-haddadin","name":"Yezan Haddadin","canonical_url":"https://registry.alpha.ac/people/yezan-haddadin"},"committee_id":"alpha:committee:outlook-therapeutics-inc:compensation","committee_name":"Compensation","role":"member","valid_from":"2017-01-01","valid_to":null,"status":"current","claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:21","evidence_ids":["alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc"],"assertion_class":"source_fact","verification_state":"source_reported"}],"committee_chairs":[],"skills":[],"fields_not_published":["age","ownership","director_compensation","attendance","overboarding"],"claim_id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850"],"assertion_class":"source_fact","verification_state":"source_reported"}],"fields_not_published":["chair","lead_independent_director","board_type","median_tenure","average_age","refreshment_rate","gender_diversity","geographic_diversity","succession_risk","overboarding","board_interlocks","attendance"]},"claims":[{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:5","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:andong-huang","object_label":"Amy (Yin-Zhen) Huang","object_source_name_forms":[],"value":"Amy (Yin-Zhen) Huang: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:andong-huang","name":"Amy (Yin-Zhen) Huang"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-01-26","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:6","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:faisal-g-sukhtian","object_label":"Faisal G. Sukhtian","object_source_name_forms":[],"value":"Faisal G. Sukhtian: Director, Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:faisal-g-sukhtian","name":"Faisal G. Sukhtian"},"title":"Director","role_category":"director","committee":"Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-01-26","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:7","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:gerd-auffarth","object_label":"Gerd Auffarth","object_source_name_forms":[],"value":"Gerd Auffarth: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:gerd-auffarth","name":"Gerd Auffarth"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-01-26","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:8","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:julia-a-haller","object_label":"Julia A. Haller","object_source_name_forms":[],"value":"Julia A. Haller: Director, Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:julia-a-haller","name":"Julia A. Haller"},"title":"Director","role_category":"director","committee":"Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-01-26","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:9","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:julian-gangolli","object_label":"Julian Gangolli","object_source_name_forms":[],"value":"Julian Gangolli: Director, Audit","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:julian-gangolli","name":"Julian Gangolli"},"title":"Director","role_category":"director","committee":"Audit","is_board_chair":false,"is_independent":true,"start_date":"2020-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2020-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-01-26","effective_from":"2020-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:10","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kurt-j-hilzinger","object_label":"Kurt J. Hilzinger","object_source_name_forms":[],"value":"Kurt J. Hilzinger: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kurt-j-hilzinger","name":"Kurt J. Hilzinger"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-01-26","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:11","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lawrence-a-kenyon","object_label":"Lawrence A. Kenyon","object_source_name_forms":[],"value":"Lawrence A. Kenyon: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lawrence-a-kenyon","name":"Lawrence A. Kenyon"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-01-26","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:12","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:ralph-h-randy-thurman","object_label":"Ralph H. Randy Thurman","object_source_name_forms":[],"value":"Ralph H. Randy Thurman: Director, Audit; Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:ralph-h-randy-thurman","name":"Ralph H. Randy Thurman"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2018-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2018-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-01-26","effective_from":"2018-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:13","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:robert-c-jahr","object_label":"Robert C. Jahr","object_source_name_forms":[],"value":"Robert C. Jahr: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:robert-c-jahr","name":"Robert C. Jahr"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-01-26","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:leadership_role:14","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:yezan-haddadin","object_label":"Yezan Haddadin","object_source_name_forms":[],"value":"Yezan Haddadin: Director, Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:yezan-haddadin","name":"Yezan Haddadin"},"title":"Director","role_category":"director","committee":"Compensation","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-01-26","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:17","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Kurt J. Hilzinger; Members Kurt J. Hilzinger (Chair); Julian Gangolli; Ralph H. Randy Thurman","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Kurt J. Hilzinger","members":[{"display_name":"Kurt J. Hilzinger","person_slug":"kurt-j-hilzinger","is_chair":true},{"display_name":"Julian Gangolli","person_slug":"julian-gangolli","is_chair":false},{"display_name":"Ralph H. Randy Thurman","person_slug":"ralph-h-randy-thurman","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:21","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Ralph H. Randy Thurman; Members Ralph H. Randy Thurman (Chair); Kurt J. Hilzinger; Yezan Haddadin","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Ralph H. Randy Thurman","members":[{"display_name":"Ralph H. Randy Thurman","person_slug":"ralph-h-randy-thurman","is_chair":true},{"display_name":"Kurt J. Hilzinger","person_slug":"kurt-j-hilzinger","is_chair":false},{"display_name":"Yezan Haddadin","person_slug":"yezan-haddadin","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0:committee_record:25","subject_id":"alpha:company:f8888e5b-ef4b-40c6-a8fa-e112334a27c0","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair Faisal G. Sukhtian; Members Faisal G. Sukhtian (Chair); Gerd Auffarth; Julia A. Haller","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":"Faisal G. Sukhtian","members":[{"display_name":"Faisal G. Sukhtian","person_slug":"faisal-g-sukhtian","is_chair":true},{"display_name":"Gerd Auffarth","person_slug":"gerd-auffarth","is_chair":false},{"display_name":"Julia A. Haller","person_slug":"julia-a-haller","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-16T04:46:51.907669+00:00","sources":[{"id":"alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:59b9372f19aa7b06f09254e62fc8e5eda7b20260b1da05087647a5d2e2ab9850","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Outlook Therapeutics, Inc. DEF 14A 2026-01-26","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":"2026-01-26","retrieved_at":"2026-04-25T00:37:01.306+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:3fe3685d7a3d238d6a72e63efa0ffd255b36fc2bda72af3313aadb125f95c0bc","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1649989/000114036126002406/ny20058729x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.84,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.907,"cross_source_agreement":0.75,"temporal_completeness":0.571},"diagnostics":{"published_claims":28,"factual_claims":28,"claims_with_linked_evidence":28,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":21,"temporal_claims_with_valid_from":12,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-16T04:46:51.907669+00:00","observed_at":"2026-10-16T04:46:51.907669+00:00","reviewed_at":"2026-10-16T04:46:51.907669+00:00","verified_at":"2026-10-16T04:46:51.907669+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":28,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/outlook-therapeutics-inc/board","section":"board","href":"https://registry.alpha.ac/api/public/companies/outlook-therapeutics-inc?format=record&section=board","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}